"Meningeal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Descriptor ID |
D008577
|
| MeSH Number(s) |
C04.588.614.250.580 C10.551.240.500
|
| Concept/Terms |
Meningeal Neoplasms- Meningeal Neoplasms
- Neoplasms, Meningeal
- Meningeal Neoplasm
- Neoplasm, Meningeal
- Meningeal Tumors
- Meningeal Tumor
- Tumor, Meningeal
- Tumors, Meningeal
Malignant Meningeal Neoplasms- Malignant Meningeal Neoplasms
- Malignant Meningeal Neoplasm
- Meningeal Neoplasm, Malignant
- Neoplasm, Malignant Meningeal
- Neoplasms, Malignant Meningeal
- Meningeal Neoplasms, Malignant
- Meningeal Cancer
- Cancer, Meningeal
- Cancers, Meningeal
- Meningeal Cancers
Intracranial Meningeal Neoplasms- Intracranial Meningeal Neoplasms
- Intracranial Meningeal Neoplasm
- Meningeal Neoplasm, Intracranial
- Neoplasm, Intracranial Meningeal
- Neoplasms, Intracranial Meningeal
- Meningeal Neoplasms, Intracranial
Leptomeningeal Neoplasms- Leptomeningeal Neoplasms
- Leptomeningeal Neoplasm
- Neoplasm, Leptomeningeal
- Neoplasms, Leptomeningeal
Spinal Meningeal Neoplasms- Spinal Meningeal Neoplasms
- Meningeal Neoplasm, Spinal
- Meningeal Neoplasms, Spinal
- Neoplasm, Spinal Meningeal
- Neoplasms, Spinal Meningeal
- Spinal Meningeal Neoplasm
Benign Meningeal Neoplasms- Benign Meningeal Neoplasms
- Benign Meningeal Neoplasm
- Meningeal Neoplasm, Benign
- Neoplasm, Benign Meningeal
- Neoplasms, Benign Meningeal
- Meningeal Neoplasms, Benign
|
Below are MeSH descriptors whose meaning is more general than "Meningeal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Meningeal Neoplasms".
This graph shows the total number of publications written about "Meningeal Neoplasms" by people in this website by year, and whether "Meningeal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 |
| 1997 | 2 | 0 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 0 | 1 | 1 |
| 2003 | 4 | 3 | 7 |
| 2004 | 4 | 2 | 6 |
| 2005 | 3 | 2 | 5 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 1 | 4 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 4 | 0 | 4 |
| 2020 | 6 | 1 | 7 |
| 2021 | 5 | 1 | 6 |
| 2022 | 5 | 0 | 5 |
| 2023 | 6 | 0 | 6 |
| 2024 | 14 | 0 | 14 |
| 2025 | 11 | 0 | 11 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Meningeal Neoplasms" by people in Profiles.
-
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients. Acta Neurochir (Wien). 2026 04 06; 168(1).
-
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results. Nat Cancer. 2026 Mar; 7(3):424-434.
-
PD-L1 positivity predicts a unique hyperaggressive tumor group within MenG C meningiomas. JNCI Cancer Spectr. 2026 Mar 03; 10(2).
-
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. J Neurooncol. 2026 Feb 09; 176(3):201.
-
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) dataset. Sci Data. 2026 Jan 27; 13(1).
-
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells. Neuro Oncol. 2025 Dec 01; 27(12):3104-3118.
-
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2026 03; 21(3):103505.
-
Treatment strategies for leptomeningeal disease in patients with breast cancer. Pharmacol Ther. 2025 12; 276:108933.
-
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis. Lancet Oncol. 2025 Sep; 26(9):1178-1190.
-
Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process. Dev Cell. 2025 Nov 03; 60(21):2880-2896.e7.